SGLT2 Inhibitors Treatment Market Size

SGLT2 Inhibitors Treatment Market size was valued at USD 6.42 billion in 2024 and is set to exceed USD 21.14 billion by 2037, registering over 9.6% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of SGLT2 inhibitors treatment is evaluated at USD 7.44 billion.

The increasing prevalence of diabetes has fuelled the demand for innovative products, advanced technologies, and personalized solutions.  According to the International Diabetes Federation, nearly 783 million adults will be living with diabetes by the end of 2045.

Government efforts to raise awareness of the disease to help in cure and diagnosis at an earlier stage are anticipated to elevate the market’s growth. Moreover, this is leading to growing awareness among people related to diabetes mellitus, and it’s treatment methods.